Viagra Ingredient Stops Cancer Spread in World First Study

< div> According to peer-reviewed research published in July in Cancer Research, sildenafil—the active ingredient in Viagra—disrupts cancer cells’ cholesterol supply to stop the spread of metastases. Researchers at the Weizmann Institute of Science, alongside teams from the US National Cancer Institute and Clalit Health Services, found that the drug targets the protein transporting essential … Read more

New Battery-Powered Device Detects Bundibugyo Ebola in 30 Minutes

Researchers at Osaka Metropolitan University (OMU), in partnership with K.K. DNAFORM and the National Institute for Biomedical Research (INRB) in the Democratic Republic of the Congo, are developing a portable, rapid diagnostic system to detect the Bundibugyo virus (BDBV). The project, supported by the Global Health Innovative Technology Fund (GHIT Fund), aims to provide field-ready, … Read more

Mexico Must Prioritize Liver Disease in Chronic Care: Expert Recommendations

Metabolic dysfunction-associated steatotic liver disease (MASLD) may affect up to 47% of adults in Mexico, according to a review published in Archives of Medical Research. Lead author Jeffrey Lazarus, a professor at the CUNY Graduate School of Public Health and Health Policy, argues that Mexico must integrate liver health into existing obesity and diabetes programs … Read more

Combating Leukemia: The Groundbreaking Link Between Weight Loss and Anti-Inflammatory Medications

Obesity May Fuel Leukemia Growth, Study Reveals Obesity may act as a catalyst for leukemia progression, according to a study led by Indiana University School of Medicine researchers. Published in the Journal of Clinical Investigation, the findings suggest that chronic inflammation linked to obesity creates an environment where leukemia cells thrive. The work, conducted by … Read more

Can Common Fitness Supplements Treat Depression?

Creatine monohydrate, a supplement widely used for muscle performance, may assist in treating major depressive disorder, according to a recent systematic review published in the journal Brain Medicine. Researchers found that while the supplement shows promise as an add-on therapy, the current evidence remains preliminary and requires further large-scale clinical trials before it can be … Read more

Improving Brain Tumor Detection with Deep Learning and Explainable AI

New deep learning frameworks for brain tumor detection are increasingly utilizing stratified patient-wise cross-validation and quantitative explainability (XAI) metrics to bridge the gap between algorithmic performance and clinical reliability. By integrating architectures like InceptionV3 with rigorous testing on independent datasets, researchers are addressing critical hurdles in medical AI, specifically data scarcity and the “black box” … Read more

Boosted Musculature May Lower Heart Attack Risk, AI Study Reveals

The Link Between Muscle Density and Heart Health People with higher skeletal muscle density in the chest and back may face a significantly lower risk of heart attacks and premature death, according to a study published in Radiology. Researchers at the University of Edinburgh used AI to analyze CT scans of 1,722 patients, finding that … Read more

First Ebola Treatment Trial Begins in Congo Outbreak

Researchers in eastern Congo have launched a clinical trial for two experimental Ebola treatments to combat the ongoing outbreak of the Bundibugyo virus. According to the World Health Organization (WHO), the trial aims to evaluate the effectiveness of Gilead Sciences’ remdesivir and Mapp Biopharmaceutical’s MBP134, as the virus has already claimed 438 lives out of … Read more

Pork Tapeworm Infection Misdiagnosed as Brain Cancer

Medical researchers in Spain have identified a rare case of neurocysticercosis, a parasitic brain infection, in a 60-year-old patient who had no history of travel to endemic regions. According to a case report published in the CDC journal Emerging Infectious Diseases, the patient’s initial symptoms of headaches and behavioral changes led physicians to suspect metastatic … Read more

New Blood Test Detects 90% of Aggressive Prostate Cancers

A new blood test, Stockholm3, detected 90% of aggressive prostate cancer cases in clinical trials, outperforming the traditional prostate-specific antigen (PSA) test, which identified 74%. According to a study published in the Annals of Internal Medicine, the test could improve early detection of curable disease while reducing unnecessary biopsies and MRIs for men aged 50 … Read more